VTRS 8-K 2026-11-05

Viatris Inc (VTRS) 8-K dated 2026-11-05 — accession 0001792044-26-000053.

Viatris Inc (VTRS) is a drug manufacturers - specialty & generic company listed on US.

VTRS revenue $3.75B

This 8-K covers: Results of operations (Item 2.02), Other events (Item 8.01), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported VTRS revenue for 2025-12-31 was $14.30B. Net income was -$3.51B. Revenue was down 3.0% from 2024-12-31 to 2025-12-31. VTRS currently screens at market cap $10.83B.

Not investment advice. The VTRS SEC hub lists recent forms. The stock page is the research view.